4.8 Article

The microglial P2Y6 receptor mediates neuronal loss and memory deficits in neurodegeneration

期刊

CELL REPORTS
卷 37, 期 13, 页码 -

出版社

CELL PRESS
DOI: 10.1016/j.celrep.2021.110148

关键词

-

资金

  1. Medical Research Council UK [MR/L010593]
  2. Alzheimer's Research UK [ARUK-DC2017-4, G-102212]
  3. Eli Lilly [ARUK-DC2017-4]
  4. LifeArc [ARUK-DC2017-4]
  5. Wellcome Trust [208363/Z/17/Z]
  6. Innovative Medicines Initiative 2 Joint Undertaking [115976]
  7. European Union
  8. EFPIA

向作者/读者索取更多资源

The P2Y(6) receptor plays a key role in mediating microglial phagocytosis of neurons induced by A beta and tau, leading to neuronal and memory loss. Knockout of this receptor could potentially be beneficial in the treatment of neurodegenerative diseases.
Microglia are implicated in neurodegeneration, potentially by phagocytosing neurons, but it is unclear how to block the detrimental effects of microglia while preserving their beneficial roles. The microglial P2Y(6) receptor (P2Y(6)R) - activated by extracellular UDP released by stressed neurons - is required for microglial phagocytosis of neurons. We show here that injection of amyloid beta (A beta) into mouse brain induces microglial phagocytosis of neurons, followed by neuronal and memory loss, and this is all prevented by knockout of P2Y(6)R. In a chronic tau model of neurodegeneration (P301S TAU mice), P2Y(6)R knockout prevented TAU-induced neuronal and memory loss. In vitro, P2Y(6)R knockout blocked microglial phagocytosis of live but not dead targets and reduced tau-, A beta-, and UDP-induced neuronal loss in glial-neuronal cultures. Thus, the P2Y(6) receptor appears to mediate A beta- and tau-induced neuronal and memory loss via microglial phagocytosis of neurons, suggesting that blocking this receptor may be beneficial in the treatment of neurodegenerative diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据